← Evidence map

TrialEmerging infectious diseases2025

Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics.

Josephine Bourner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39983682